In vivo MR angiography and velocity measurement in mice coronary arteries at 9.4 T: assessment of coronary flow velocity reserve.

PURPOSE To demonstrate the feasibility of coronary magnetic resonance (MR) angiography in living mice and to evaluate a dynamic MR angiographic method for coronary flow measurement at 9.4-T field strength. MATERIALS AND METHODS This study was conducted according to European law and was in full compliance with National Institutes of Health recommendations for animal care and a local institutional animal care committee. Mice were anesthetized by using isoflurane. First, time-of-flight MR angiography was performed in 10 mice to measure coronary diameters at 80-mum isotropic resolution. Second, left coronary artery (LCA) velocity measurements were performed at seven cardiac phases in nine other mice to assess the velocity curve profile. Third, coronary velocities were measured at the middiastolic phase in 13 mice at rest and during adenosine-induced hyperemia to calculate coronary flow velocity reserve (CFVR). The Pearson coefficient compared the correlation between isoflurane dose and CFVR. Paired t tests compared R-R intervals and respiratory rates between rest and hyperemia. RESULTS Proximal diameters were, respectively, 404 mum +/- 34 [standard deviation] and 259 mum +/- 22 for the LCAs and the right coronary arteries, which were in accordance with reported values. The velocity curve profile throughout the cardiac cycle was similar to values from the literature. Baseline and hyperemic velocities were, respectively, 19.0 cm/sec +/- 4.4 and 33.7 cm/sec +/- 4.7 (P<.001), resulting in a CFVR of 1.77 +/- 0.19. CFVR did not correlate with isoflurane dose (r = 0.05, P = .88). R-R intervals shortened by 2.5% during hyperemia (P = .04). Respiratory rates showed no difference between rest and hyperemia (P = .39). CONCLUSION High-spatial-resolution three-dimensional coronary MR angiography is feasible in living mice. Dynamic MR angiography depicts coronary velocity changes throughout the cardiac cycle and between rest and maximum hyperemia, providing a tool for CFVR assessment.

[1]  G. Fakhri,et al.  Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  K. Hirata,et al.  Mouse Coronary Angiograph Using Synchrotron Radiation Microangiography , 2002 .

[3]  Monique Bernard,et al.  Myocardial blood flow mapping in mice using high‐resolution spin labeling magnetic resonance imaging: Influence of ketamine/xylazine and isoflurane anesthesia , 2005, Magnetic resonance in medicine.

[4]  René M. Botnar,et al.  Coronary magnetic resonance angiography for the detection of coronary stenoses. , 2001, The New England journal of medicine.

[5]  C D Claussen,et al.  Accuracy and reliability of quantitative measurements in coronary arteries by multi-slice computed tomography: experimental and initial clinical results. , 2001, Clinical radiology.

[6]  J. Franconi,et al.  Blood velocity assessment using 3D bright‐blood time‐resolved magnetic resonance angiography , 2006, Magnetic resonance in medicine.

[7]  K. Hirata,et al.  In vivo angiographic detection of vascular lesions in apolipoprotein E-knockout mice using a synchrotron radiation microangiography system. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[8]  R. Wilson,et al.  Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. , 1985, Circulation.

[9]  M. Viergever,et al.  Limits to the accuracy of vessel diameter measurement in MR angiography , 1998, Journal of magnetic resonance imaging : JMRI.

[10]  L. Gan,et al.  Adenosine induces dilation of epicardial coronary arteries in mice: relationship between coronary flow velocity reserve and coronary flow reserve in vivo using transthoracic echocardiography. , 2008, Ultrasound in medicine & biology.

[11]  M. Saraste,et al.  Technical achievement: transthoracic Doppler echocardiography can be used to detect LAD restenosis after coronary angioplasty. , 2000, Clinical physiology.

[12]  J. Wikström Imaging of coronary artery function and morphology in living mice - applications in atherosclerosis research , 2007 .

[13]  K. Hirata,et al.  Images in cardiovascular medicine. Mouse coronary angiograph using synchrotron radiation microangiography. , 2002, Circulation.

[14]  T Akasaka,et al.  Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. , 1998, Circulation.

[15]  G. Bergström,et al.  Functional and morphologic imaging of coronary atherosclerosis in living mice using high-resolution color Doppler echocardiography and ultrasound biomicroscopy. , 2005, Journal of the American College of Cardiology.

[16]  M A Horsfield,et al.  A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. , 1999, Journal of the American College of Cardiology.

[17]  Judkins Mp Percutaneous transfemoral selective coronary arteriography. , 1968 .

[18]  T Akasaka,et al.  Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. , 1998, Journal of the American College of Cardiology.

[19]  G. Bergström,et al.  Non‐invasive imaging of coronary arteries in living mice using high‐resolution echocardiography , 2004, Scandinavian cardiovascular journal : SCJ.

[20]  W. Hundley,et al.  Measurement of absolute epicardial coronary artery flow and flow reserve with breath-hold cine phase-contrast magnetic resonance imaging. , 1995, Circulation.

[21]  W. Wijns,et al.  Intracoronary and Intravenous Adenosine 5′-Triphosphate, Adenosine, Papaverine, and Contrast Medium to Assess Fractional Flow Reserve in Humans , 2003, Circulation.

[22]  F. Foster,et al.  Comprehensive transthoracic cardiac imaging in mice using ultrasound biomicroscopy with anatomical confirmation by magnetic resonance imaging. , 2004, Physiological genomics.

[23]  P. Carmeliet,et al.  Transgenic mouse models in angiogenesis and cardiovascular disease , 2000, The Journal of pathology.

[24]  A Haase,et al.  Magnetic resonance imaging of coronary arteries and heart valves in a living mouse: techniques and preliminary results. , 2000, Journal of magnetic resonance.

[25]  J. S. Cole,et al.  The Pulsed Doppler Coronary Artery Catheter , 1977 .

[26]  E. Hoffman,et al.  N-13 Labeled Ammonia and Positron Emission Computerized Axial Tomography , 1979 .

[27]  S. Kaul,et al.  Detection of coronary stenoses and quantification of the degree and spatial extent of blood flow mismatch during coronary hyperemia with myocardial contrast echocardiography. , 1995, Circulation.

[28]  E. Croteau,et al.  Quantitative myocardial perfusion and coronary reserve in rats with 13N-ammonia and small animal PET: impact of anesthesia and pharmacologic stress agents. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  R R Edelman,et al.  Flow velocity quantification in human coronary arteries with fast, breath‐hold MR angiography , 1993, Journal of magnetic resonance imaging : JMRI.

[30]  S. Miraux,et al.  In vivo quantification of blood velocity in mouse carotid and pulmonary arteries by ECG‐triggered 3D time‐resolved magnetic resonance angiography , 2009, NMR in biomedicine.

[31]  S. Madala,et al.  Effects of isoflurane on coronary blood flow velocity in young, old and ApoE(-/-) mice measured by Doppler ultrasound. , 2007, Ultrasound in medicine & biology.

[32]  J. Thüroff,et al.  Diameter of coronary arteries in 36 species of mammalian from mouse to giraffe , 1984, Basic Research in Cardiology.